Cigna modified MM 0538, its flow cytometry coverage policy, effective October 16, 2025. Here's what billing teams need to do.
Cigna Healthcare updated Coverage Policy MM 0538 governing flow cytometry testing. This change affects 14 CPT codes — including 88184, 88185, 88187, 88188, and 88189 for technical and interpretation components — across hematology, oncology, immunology, and transplant medicine. If your practice or lab bills flow cytometry for hematologic malignancies, HIV/AIDS monitoring, or post-transplant surveillance, this policy update is worth a careful read before October 16, 2025.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Flow Cytometry - (0538) |
| Policy Code | MM 0538 |
| Change Type | Modified |
| Effective Date | October 16, 2025 |
| Impact Level | High |
| Specialties Affected | Hematology, Oncology, Infectious Disease, Immunology, Transplant Medicine, Clinical Laboratory |
| Key Action | Audit active flow cytometry claims for ICD-10 alignment and update charge capture for CPT 88184–88189 before October 16, 2025 |
Cigna Flow Cytometry Coverage Criteria and Medical Necessity Requirements 2025
The Cigna flow cytometry coverage policy under MM 0538 ties medical necessity to a defined set of clinical indications. Flow cytometry — the lab technique used to separate, classify, and count cell populations — is covered when ordered for diagnosis or evaluation of hematologic cancers, HIV/AIDS, primary immunodeficiency disorders, molar pregnancies, paroxysmal hemoglobinuria, or monitoring after transplantation.
All 14 CPT codes under this policy are designated "Considered Medically Necessary when criteria in the applicable coverage section are met." That language is doing a lot of work. It means coverage isn't automatic — the diagnosis on the claim must align with Cigna's approved indication list, and your documentation must support it.
The marker interpretation codes carry their own logic. CPT 88187 covers interpretation of two to eight markers. CPT 88188 covers nine to 15 markers. CPT 88189 covers 16 or more markers. Bill the code that matches the number of markers actually interpreted, as documented in the lab report.
CPT 88184 covers the technical component for the first marker. Each additional marker uses CPT 88185. These pair with the interpretation codes — make sure your lab is capturing both components if you perform and interpret in-house.
The specialty immunology codes — 86355 (B cells), 86357 (NK cells), 86359 (T cells, total count), 86360 (CD4/CD8 absolute count with ratio), 86361 (absolute CD4), and 86367 (CD34 stem cells) — each require a covered indication to be present on the claim. For HIV management specifically, CD4 monitoring via 86360 and 86361 maps directly to ICD-10 B20. If your infectious disease practice orders these routinely, confirm your ICD-10 assignment before October 16.
CPT 0581U is the proprietary lab test code for non-HLA antibody testing via flow cytometry in transplant medicine. It falls under the same medical necessity criteria framework. If your transplant center bills 0581U, the covered indication must tie to post-transplant monitoring — not a general pre-transplant workup without documented clinical rationale.
Cigna Flow Cytometry Exclusions and Non-Covered Indications
The policy data does not enumerate a separate experimental or non-covered code list for MM 0538. Every CPT code in this policy carries the same conditional language: covered when criteria are met.
The practical exclusion is any claim where the ICD-10 code on the claim falls outside the covered indication list. Cigna's ICD-10 list for this policy runs to 235 codes. That's a wide net — but it has edges. Flow cytometry ordered for general wellness panels, undifferentiated symptom coding, or diagnoses that don't map to the policy's covered indications will deny.
The real issue here is specificity. A claim for CPT 88184–88189 with an unspecified or low-acuity ICD-10 will draw scrutiny. If the clinical picture supports a covered diagnosis — say, suspected lymphoma or confirmed HIV disease — code to the highest level of specificity the documentation supports.
Coverage Indications at a Glance
Editorial note: The table below summarizes covered clinical indications based on the MM 0538 policy summary and ICD-10 code list. All 14 CPT codes under this policy are covered when medical necessity criteria are met — the source does not map specific CPT codes to specific indications. The ICD-10 codes shown are drawn from the source data and are not exhaustive. Verify all code assignments against the full MM 0538 policy text before billing.
| Indication | Status | Key ICD-10 Codes (from source data) |
|---|---|---|
| Hematologic cancers (leukemia, lymphoma, myeloma) | Covered — criteria required | C81.00–C81.9A, C82.00–C82.9A, C83.00–C83.xx, C84.00–C84.xx, C85.10–C85.xx, C86.00–C86.61, C88.00–C88.91, C90.00–C90.32, C91.00–C91.92, C92.00–C92.92, C93.00–C93.92, C94.00–C94.82, C95.00–C95.92, C96.0–C96.9 |
| HIV/AIDS diagnosis and monitoring | Covered — criteria required | B20, B97.35 |
| Primary immunodeficiency disorders | Covered — criteria required | See full MM 0538 policy for complete ICD-10 list |
| Post-transplant monitoring | Covered — criteria required | D47.Z1 (PTLD) |
| Molar pregnancy / placental neoplasm | Covered — criteria required | C58, D39.2 |
| Paroxysmal hemoglobinuria | Covered — criteria required | See full MM 0538 policy for complete ICD-10 list |
| Myelodysplastic syndromes | Covered — criteria required | D46.0–D46.xx |
| Mastocytosis | Covered — criteria required | D47.01, D47.02, D47.09 |
| Polycythemia vera / myeloproliferative disease | Covered — criteria required | D45, D47.1, D47.3, D47.4 |
| Monoclonal gammopathy | Covered — criteria required | D47.2 |
| Opportunistic infections in immunocompromised patients | Covered — criteria required | B20, B37.1, B37.81, B45.0–B45.9, B58.2, B59 |
| HTLV-I / HTLV-II associated disease | Covered — criteria required | B97.33, B97.34 |
All 14 CPT codes listed under MM 0538 are covered when medical necessity criteria are met. The source does not designate specific CPT codes for specific indications. View the complete ICD-10 list on PayerPolicy →
Cigna Flow Cytometry Billing Guidelines and Action Items 2025
| # | Action Item |
|---|---|
| 1 | Audit your active flow cytometry charge master before October 16, 2025. Pull every claim line that uses CPT 88184, 88185, 88187, 88188, or 88189 and verify the attached ICD-10 code maps to a covered indication under MM 0538. Claims that go out after the effective date with mismatched diagnosis codes will deny — and retro-appeals on medical necessity denials are expensive to work. |
| 2 | Reconcile marker counts on interpretation claims. CPT 88187, 88188, and 88189 are billed based on markers interpreted — two to eight, nine to 15, and 16 or more, respectively. Pull a sample of recent claims and compare the billed code to the lab report. If there's drift, fix the charge capture logic now. |
| 3 | Separate technical and professional components correctly. If your lab performs the technical work (88184, 88185) and a physician interprets separately (88187, 88188, or 88189), confirm each component is billed correctly. Talk to your compliance officer or billing consultant if you're unsure how your facility's setup applies here — split-billing scenarios for flow cytometry can get complicated quickly. |
| 4 | Update ICD-10 crosswalk documentation for transplant cases using 0581U. CPT 0581U — non-HLA antibody testing via flow cytometry — sits under the same MM 0538 criteria. Post-transplant lymphoproliferative disorder (D47.Z1) is explicitly in the covered diagnosis list. Make sure your transplant billing team knows to use that code where documented rather than defaulting to unspecified neoplasm codes. |
| 5 | Train ordering providers on documentation requirements. A covered indication in the ICD-10 list is necessary but not sufficient on its own. Cigna's medical necessity standard requires that the clinical picture support the test. Make sure the ordering note documents why flow cytometry was clinically indicated — not just the diagnosis. This is your first line of defense in a claim denial appeal. |
| 6 | If you're billing CD34 counts (86367) for stem cell collection or transplant preparation, confirm the indication. This code is covered for transplant-related monitoring, but billing it against a diagnosis that doesn't fall within the policy's approved indications is a fast path to denial and potential audit risk. If you're unsure how your mix maps to these criteria, loop in your compliance officer before the effective date. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Flow Cytometry Under MM 0538
Covered CPT Codes (When Medical Necessity Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 0581U | CPT (PLA) | Transplantation medicine, antibody to non-human leukocyte antigens (non-HLA), blood specimen, flow cytometry |
| 86355 | CPT | B cells, total count |
| 86356 | CPT | Mononuclear cell antigen, quantitative (e.g., flow cytometry), not otherwise specified, each antigen |
| 86357 | CPT | Natural killer (NK) cells, total count |
| 86359 | CPT | T cells; total count |
| 86360 | CPT | T cells; absolute CD4 and CD8 count, including ratio |
| 86361 | CPT | T cells; absolute CD4 count |
| 86367 | CPT | Stem cells (i.e., CD34), total count |
| 88182 | CPT | Flow cytometry, cell cycle or DNA analysis |
| 88184 | CPT | Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker |
| 88185 | CPT | Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker |
| 88187 | CPT | Flow cytometry, interpretation; 2 to 8 markers |
| 88188 | CPT | Flow cytometry, interpretation; 9 to 15 markers |
| 88189 | CPT | Flow cytometry, interpretation; 16 or more markers |
Key ICD-10-CM Diagnosis Codes
This policy covers 235 ICD-10 codes. Below are the highest-volume and highest-stakes codes your billing team should know cold.
| Code | Description |
|---|---|
| B20 | Human immunodeficiency virus [HIV] disease |
| B97.33 | HTLV-I as the cause of diseases classified elsewhere |
| B97.34 | HTLV-II as the cause of diseases classified elsewhere |
| B97.35 | HIV-2 as the cause of diseases classified elsewhere |
| B59 | Pneumocystosis |
| B37.1 | Pulmonary candidiasis |
| B37.81 | Candidal esophagitis |
| B45.0–B45.9 | Cryptococcosis |
| B58.2 | Toxoplasma meningoencephalitis |
| C46.0–C46.9 | Kaposi's sarcoma |
| C53.0–C53.9 | Malignant neoplasm of cervix uteri |
| C58 | Malignant neoplasm of placenta |
| C81.00–C81.9A | Hodgkin lymphoma |
| C82.00–C82.9A | Follicular lymphoma |
| C83.00–C83.xx | Non-follicular lymphoma |
| C84.00–C84.xx | Mature T/NK-cell lymphomas |
| C85.10–C85.xx | Other specified and unspecified types of non-Hodgkin lymphoma |
| C86.00–C86.61 | Other specified types of T/NK-cell lymphoma |
| C88.00–C88.91 | Malignant immunoproliferative diseases and certain other B-cell lymphomas |
| C90.00–C90.32 | Multiple myeloma and malignant plasma cell neoplasms |
| C91.00–C91.92 | Lymphoid leukemia |
| C92.00–C92.92 | Myeloid leukemia |
| C93.00–C93.92 | Monocytic leukemia |
| C94.00–C94.82 | Other leukemias of specified cell type |
| C95.00–C95.92 | Leukemia of unspecified cell type |
| C96.0–C96.9 | Other and unspecified malignant neoplasms of lymphoid, hematopoietic, and related tissue |
| D39.2 | Neoplasm of uncertain behavior of placenta |
| D45 | Polycythemia vera |
| D46.0–D46.xx | Myelodysplastic syndromes |
| D47.01 | Cutaneous mastocytosis |
| D47.02 | Systemic mastocytosis |
| D47.09 | Other mast cell neoplasms of uncertain behavior |
| D47.1 | Chronic myeloproliferative disease |
| D47.2 | Monoclonal gammopathy |
| D47.3 | Essential (hemorrhagic) thrombocythemia |
| D47.4 | Osteomyelofibrosis |
| D47.Z1 | Post-transplant lymphoproliferative disorder (PTLD) |
| A02.1 | Salmonella sepsis |
| A07.2 | Cryptosporidiosis |
| A07.3 | Isosporiasis |
| A15.0–A19.9 | Tuberculosis |
| A31.0 | Pulmonary mycobacterial infection |
| A31.2 | Disseminated mycobacterium avium-intracellulare complex (DMAC) |
| A31.8 | Other mycobacterial infections |
| A81.2 | Progressive multifocal leukoencephalopathy |
| B00.0 | Eczema herpeticum |
| B00.1 | Herpesviral vesicular dermatitis |
| B00.2 | Herpesviral gingivostomatitis and pharyngotonsillitis |
| B00.89 | Other herpesviral infection |
| B25.0–B25.9 | Cytomegaloviral disease |
| B37.89 | Other sites of candidiasis |
| B38.9 | Coccidioidomycosis, unspecified |
| B39.2 | Pulmonary histoplasmosis capsulati, unspecified |
| B39.3 | Disseminated histoplasmosis capsulati |
| B39.4 | Histoplasmosis capsulati, unspecified |
The full ICD-10 list for MM 0538 includes 235 codes. View the complete list on PayerPolicy →
Get the Full Picture for CPT 88184
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.